“…HECs undergo a highly-conserved 'endothelial-tohematopoietic transition' (EHT) process (Ciau-Uitz & Patient, 2019, Dzierzak & Bigas, 2018, Dzierzak & Speck, 2008, Jaffredo, Nottingham et al, 2005. Transcriptomics and loss-of-function studies have identified candidate regulators/signaling pathways in transitioning cells (Gao, Chen et al, 2020, Li, Gao et al, 2017, Lichtinger, Ingram et al, 2012, Moignard, Woodhouse et al, 2015, Porcheri, Golan et al, 2020, Swiers, Baumann et al, 2013, Zhou, Li et al, 2016.…”